News
The company has obtained six approvals.
Release time:
2019-12-24
On December 13, 2019, Langbo Pharmaceutical obtained 6 official approvals, consisting of 4 renewals and 2 new product applications. The new products are Carbapirin Calcium Soluble Powder 50% and Compound Sulfachlorodazine Sodium Powder. Following preliminary market research, product information collection, and discussion screening, we finally determined these two as the new products for application. Through planning, coordination meetings, and clear task division, and with the active cooperation of various departments, we conducted small-scale sample preparation and stability testing. After confirming the process was stable and feasible, we carried out trial production for 3 batches. Through on-site inspection sampling and provincial institute re-inspection, we submitted the application materials as required, passed the Provincial Bureau review, and finally obtained the formal approvals from the Department of Agriculture and Rural Affairs.
On December 13, 2019, Langbo Pharmaceutical received 6 approvals issued by the Ministry of Agriculture and Rural Affairs of the People's Republic of China. Among them, Carbapirin Calcium Soluble Powder (Veterinary Drug No. 110082313) and Compound Sulfachlorodazine Sodium Powder (Veterinary Drug No. 110082252) are new products, while the other 4 are renewals of existing products. Carbapirin Calcium Soluble Powder is an antipyretic, analgesic, and anti-inflammatory drug. It is a salt complex of calcium aspirin and urea. After oral administration, Carbapirin Calcium is rapidly absorbed and primarily metabolized in the liver, where it quickly degrades into salicylic acid to exert its antipyretic, analgesic, and anti-inflammatory effects. Compound Sulfachlorodazine Sodium Powder is a broad-spectrum antibiotic that also possesses coccidiocidal activity, capable of rapidly addressing the primary causes of enterotoxicosis syndrome.
The approval of these new products has further enriched our veterinary drug product line. In the future, we will fully leverage our industrial chain advantages integrating R&D, production, and sales, continue to focus precisely on the field of animal health, and strive to fulfill our mission of "Carefully Protecting Health."


More news